Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study.
Genovese MC, Spindler A, Sagawa A, Park W, Dudek A, Kivitz A, Chao J, Chan LSM, Witcher J, Barchuk W, Nirula A. Genovese MC, et al. Among authors: sagawa a. J Rheumatol. 2021 Jul;48(7):969-976. doi: 10.3899/jrheum.200893. Epub 2020 Dec 15. J Rheumatol. 2021. PMID: 33323529 Clinical Trial.
Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis.
Kameda H, Fujii T, Nakajima A, Koike R, Sagawa A, Kanbe K, Tomita T, Harigai M, Suzuki Y; Japan College of Rheumatology subcommittee on the guideline for the use of methotrexate in patients with rheumatoid arthritis. Kameda H, et al. Among authors: sagawa a. Mod Rheumatol. 2019 Jan;29(1):31-40. doi: 10.1080/14397595.2018.1472358. Epub 2018 May 24. Mod Rheumatol. 2019. PMID: 29718746
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial.
Fujieda Y, Horita T, Nishimoto N, Tanimura K, Amasaki Y, Kasahara H, Furukawa S, Takeda T, Fukaya S, Matsui K, Tsutsumi A, Furusaki A, Sagawa A, Katayama K, Takeuchi K, Katsumata K, Kurita T, Shane P, Kato M, Oku K, Yasuda S, Takahata M, Iwasaki N, Atsumi T. Fujieda Y, et al. Among authors: sagawa a. Mod Rheumatol. 2021 May;31(3):593-599. doi: 10.1080/14397595.2020.1812835. Epub 2020 Oct 2. Mod Rheumatol. 2021. PMID: 32820698 Clinical Trial.
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Sawada T, Inokuma S, Sato T, Otsuka T, Saeki Y, Takeuchi T, Matsuda T, Takemura T, Sagawa A; Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology. Sawada T, et al. Among authors: sagawa a. Rheumatology (Oxford). 2009 Sep;48(9):1069-72. doi: 10.1093/rheumatology/kep052. Epub 2009 Mar 25. Rheumatology (Oxford). 2009. PMID: 19321513
A multicenter study of leukocytapheresis in rheumatoid arthritis.
Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda H, Tohma S, Suzuki K, Tominaga M, Kawabe Y, Mine M, Honda S, Tsukano M, Nakamura T, Hidaka T, Eguchi K. Ueki Y, et al. Among authors: sagawa a. Clin Exp Rheumatol. 2007 Nov-Dec;25(6):810-6. Clin Exp Rheumatol. 2007. PMID: 18173913
Comparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
Horikoshi M, Suzuki T, Sugihara M, Kondo Y, Tsuboi H, Uehara T, Hama M, Takase K, Ohno S, Ishigatsubo Y, Yoshida Y, Sagawa A, Ikeda K, Ota T, Matsumoto I, Ito S, Sumida T. Horikoshi M, et al. Among authors: sagawa a. Mod Rheumatol. 2010 Dec;20(6):556-60. doi: 10.1007/s10165-010-0318-2. Epub 2010 Jun 4. Mod Rheumatol. 2010. PMID: 20524026
90 results